Literature DB >> 29914710

[Bisalbuminemia: A case report].

B Lefrère1, E Dedôme2, C Garcia-Hejl2, C Ragot2, D Chianea2, H Delacour3, S Cremades4, P Vest2.   

Abstract

INTRODUCTION: Bisalbuminemias consist in rare qualitative modifications of several aspects in the albumin pattern. Bisalbuminemias, most of which are not pathological, can be observed using capillary electrophoresis. CASE REPORTS: We report a case of hereditary bisalbuminemia diagnosed by chance while exploring chronic unexplained hypereosinophilia in a 42-year-old patient. The patient's normal lipid profile, the lack of an antibiotic treatment or pancreatic pathology, and the persistence of the bisalbuminemia after one month, suggested a diagnosis of genetic bisalbuminemia. In light of other such cases, we review the main causes of bisalbuminemia, both genetic and acquired.
CONCLUSION: The diagnosis of genetic bisalbuminemia is made by first eliminating the usual acquired etiologies: analytical or drug interference, acute pancreatitis and binding of immunoglobulins. Then, after having checked the lipemic index, reviewed the patient's medical history, comorbidities, and treatments, repeating the electrophoresis will help identify the cause of the bisalbuminemia.
Copyright © 2018 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bisalbuminemia; Bisalbuminémie; Drug interference; Interférence médicamenteuse; Serum protein electrophoresis; Électrophorèse des protéines sériques

Mesh:

Substances:

Year:  2018        PMID: 29914710     DOI: 10.1016/j.revmed.2018.05.010

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  1 in total

1.  [Unusual serum protein electrophoresis in a patient with cholangiocarcinoma].

Authors:  Aboubacar Dit Tietie Bissan; Amadou Diawara; Raoul Karfo; Aboubakre Teguete; Oumar Tangara; Alpha Guindo; Fatoumata Maïga; Etienne Algiman
Journal:  Pan Afr Med J       Date:  2020-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.